Barclays lowered the firm’s price target on Aspen Aerogels (ASPN) to $3 from $4 and keeps an Underweight rating on the shares. The company missed expectations as weakness in the GM electric vehicle outlook persists, the analyst tells investors in a research note.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ASPN:
- Aspen Aerogels price target lowered to $6 from $7 at TD Cowen
- Aspen Aerogels price target lowered to $4 from $10 at B. Riley
- Aspen Aerogels price target lowered to $3 from $6 at Roth Capital
- Aspen Aerogels Charts Cost-Cut Path Amid EV Slowdown
- Aspen Aerogels Launches Strategic Review Amid 2025 Downturn